News -

Check out the posts below to learn the latest updates on our progress

November 13 2019F1 Oncology’s International Affiliate, EXUMA Biotechnology, Announces Acquisition of Strategic CAR-T Assets
June 18 2019Exuma Biotechnology Expands Leadership Team with Appointment of Chief Medical Officer and Chief Financial OfficerPRNewswire
May 21 2019Shanghai Perhum Therapeutics Announces Preliminary Results Of Two First-in-Human Solid Tumor CAR-T ProductsPRNewswire
January 6 2017BioAtla and F1 Oncology Announce Global Collaboration to Develop Adoptive Cellular Therapies for Solid Tumors